Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 17
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    How do chimpanzees adapt to a savanna woodland in Tanzania?

    75% of Tanzania’s chimpanzees live in open “savanna” woodlands. Considered a marginal habitat due to low food...

    Engineering rhizobacteria to improve crop yields and drought resistance in legumes

    Fertilizers used in agriculture have significant environmental effects like toxic algal blooms and biodiversity...

    Backer Badge Funded